Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-26 10:01 am Purchase | 2024-08-19 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 149,371 10.090% | 96,300 (+181.46%) | Filing History |
| 2024-07-01 06:47 am Sale | 2024-06-21 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 53,071 3.580% | -96,300 (-64.47%) | Filing History |
| 2024-05-10 2:14 pm Sale | 2024-04-30 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | -7,505,539 (Position Closed) | Filing History |
| 2024-02-14 4:03 pm Sale | 2023-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management, LLC | 70,000 4.700% | -33,833 (-32.58%) | Filing History |
| 2024-02-14 10:55 am Purchase | 2023-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 7,505,539 16.910% | 7,237,908 (+2704.44%) | Filing History |
| 2023-12-04 06:01 am Sale | 2023-11-14 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 149,371 10.090% | -33 (-0.02%) | Filing History |
| 2023-11-24 06:01 am Unchanged | 2023-11-14 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 149,404 10.090% | 0 (Unchanged) | Filing History |
| 2023-11-02 9:54 pm Purchase | 2023-11-02 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 179,174 12.130% | 9,275 (+5.46%) | Filing History |
| 2023-10-20 4:29 pm Purchase | 2023-10-18 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 169,900 11.510% | 9,102 (+5.66%) | Filing History |
| 2023-09-28 4:54 pm Purchase | 2023-09-14 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 160,798 10.900% | 81,059 (+101.66%) | Filing History |
| 2023-08-15 06:00 am Purchase | 2023-08-02 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 79,739 5.400% | 79,739 (New Position) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 31,238 2.100% | -63,952 (-67.18%) | Filing History |
| 2023-04-18 09:59 am Purchase | 2023-04-10 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 149,404 10.150% | 58,971 (+65.21%) | Filing History |
| 2023-04-10 1:37 pm Purchase | 2023-02-28 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 267,631 18.220% | 86,139 (+47.46%) | Filing History |
| 2023-02-14 2:23 pm Sale | 2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management, LLC | 103,833 7.100% | -6,167 (-5.61%) | Filing History |
| 2023-02-09 10:57 am Sale | 2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -93,333 (Position Closed) | Filing History |
| 2023-02-06 3:34 pm Purchase | 2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 95,190 6.500% | 12,758 (+15.48%) | Filing History |
| 2023-02-02 2:25 pm Purchase | 2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 90,433 6.160% | 29,559 (+48.56%) | Filing History |
| 2023-01-10 12:12 pm Sale | 2022-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 181,492 12.350% | -71,512 (-28.27%) | Filing History |
| 2022-05-11 3:01 pm Purchase | 2022-05-06 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 253,004 17.560% | 18,043 (+7.68%) | Filing History |